Eam Global Investors LLC Tg Therapeutics, Inc. Transaction History

Eam Global Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $545,188 - $1.29 Million	108,820 New	108,820 $1.29 Million
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $916,857 - $1.38 Million	-28,211 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$41.61 - $54.3 $159,948 - $208,729	-3,844 Reduced 11.99%	28,211 $1.36 Million
Q4 2020 Feb 11, 2021	SELL	$25.27 - $54.9 $837,119 - $1.82 Million	-33,127 Reduced 50.82%	32,055 $1.67 Million
Q3 2020 Nov 13, 2020	SELL	$18.49 - $27.24 $570,342 - $840,245	-30,846 Reduced 32.12%	65,182 $1.74 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $854,649 - $2.1 Million	96,028 New	96,028 $1.87 Million

347

88M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.85B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.